June 2006 Issue of MMM
Here is the news: Big, bad television and the untrustworthy Internet are driving droves of patients to their doctors to request specific drugs by name.
With the direct-to-patient movement well underway, pharmaceutical marketers are getting savvier at striking a chord with their patients in the quest for compliance.
The once-exploding ADHD market has been tempered of late. And as drug firms continue to battle bad press and tough regulations, a pipeline challenge looms: ...
A study of consumer preferences for seeking and using information
Blogs are legion. Pharmaceuticals are a favorite topic of many, and a few are highly influential with patients and the press. How should companies engage ...
For marketers, talking with colleagues in R&D is key to optimal product positioning and in-sync messaging. Marc Iskowitz looks at how early collaboration between the ...
Genentech's Bill Anderson says he has always felt a drive to make a difference in people's lives.
Med Ed Report
New data support something medical education companies have long contended: They are more compliant with requirements for commercial support and less likely to be on ...
Cardinal Health is offering its medical-education business for sale as part of a plan to divest its Healthcare Marketing Services (HMS) division.
Lori Bainbridge has joined inRx Medical Education as director of medical education, a new position.
Wolters Kluwer Health has separated its continuing medical and pharmacy education unit into a subsidiary company.
M|C Communications says Harvard Medical School will provide content for Pri-Med Patient Education Center, a venture introducing multimedia education systems into physicians' waiting rooms.
Interlink Healthcare Communications, a unit of Lowe Healthcare Worldwide, has hired Sara Mariani, MD, PhD, as medical director.
About.com upped the ante on its health offering, bringing on Marjorie Martin from archrival WebMD to head About Health (health.about.com).
The Vendome Group is relaunching Postgraduate Medicine as a beefed-up bimonthly and reintroducing the title's CME program.
Nature Clinical Practice has partnered with the American College of Gastroenterology and the World Heart Federation.
Diabetes Technology & Therapeutics, a Medline journal published by Mary Ann Liebert, named Satish K. Garg, MD, editor in chief.
Dowden Health Media has named Jennifer J. Day SVP, professional division.
TNS numbers indicated a slight decline in pharmaceutical online advertising for 2005. Does this indicate a downswing in overall online spending, or a shift to ...
Online ad sales have become a fairly good barometer of how the Internet is doing as an industry.
Doctors are spending more time online, with more of their Internet activities devoted to professional endeavors, according to the results of a new survey conducted ...
Digital marketing firm One to One Interactive has named Gayatri Bhalla group director of its life sciences division.
Most pharmaceutical sales reps believe PhRMA's Code on Interactions with Healthcare Professionals is negatively impacting their jobs, according to a recent study by market research ...
The US Postal Service last month filed for an average 8.5% postal rate increase.
AstraZeneca and Biovail have entered into an agreement in which Biovail's specialty sales force will promote AstraZeneca's Zoladex (goserelin acetate implant) to obstetricians and gynecologists ...
Healthpoint has named Jay Speelhoffer VP of sales for the pharmaceutical company's tissue management division.
Xchange, the relationship-marketing unit of CommonHealth, has made three new hires and a promotion.
Consumer group Community Catalyst announced its second annual Bitter Pill Awards, skewering the makers of Ambien, Lunesta and Strattera, among others, for what it deems ...
LLNS and TBWA Worldhealth named Anne Devereux CEO.
PhRMA named four members of its Guiding Principles independent review panel on DTC.
Sally Field will be the face of an osteoporosis awareness campaign aimed at boomer women over 50 by Boniva makers Roche and GSK.
AstraZeneca will not run TV or print ads for its recently approved pediatric indication on Nexium.
Why should marketers allocate more help-seeking DTC spending to PR?
Bradley Pharmaceuticals' Doak Dermatologics division launched its Skin Cancer Screening Tour, a corporate campaign featuring a 38-foot "Mobile Diagnosis Vehicle" popping up at sun-drenched events ...
Cohn & Wolfe healthcare head Jennifer Gottlieb has jumped ship to bicoastal boutique Weisscom Partners.
Women wept in the streets when the FDA's first commissioner left office in 1912.
New disclosures show that former FDA commissioner Lester Crawford took the unprecedented step of assuming all decision-making authority on the OTC Plan B emergency contraceptive, ...
The FDA is asking for comment on two proposed studies to evaluate types of content and format for use in a revised brief summary for ...
There's "a certain amount of hypocrisy" in Sen. Chuck Grassley's current probe of drug company involvement in CME programs, writes industry attorney Jeffrey N. Gibbs ...
"How does the FDA regard signage or billboards advertising pharmaceutical products that are prominently displayed at ballparks and other sports stadiums, and which may be ...
The weekly Cancer Letter says recent Capitol Hill testimony by the acting director of the National Cancer Institute (NCI) suggests that human papilloma virus (HPV) ...
A federal judge ruled the FDA improperly denied generic drug makers Ranbaxy and Ivax rights to 180 days of marketing exclusivity.
In my agency days, I always wanted to see firsthand how well the sales aids we created worked in the field.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.